Skip to content
10-Q

Quarterly Report

Echo Therapeutics, Inc.

0001415889-16-006793

← back to feed
Filed
Aug 12, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 3, 2016 11.54M sh
Operating Cash Flow Q2 2016 · Jun 30, 2016 −$3.31M
Operating Cash Flow restated Q2 2016 · Jun 30, 2015 −$3.43M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $938.66K
Cash And Equivalents Q2 2016 · Dec 31, 2015 $56.21K
Cash And Equivalents Q2 2016 · Jun 30, 2015 $337.42K
Cash And Equivalents Q2 2016 · Dec 31, 2014 $1.28M
Stockholders Equity Q2 2016 · Jun 30, 2016 −$7.37M
Stockholders Equity Q2 2016 · Dec 31, 2015 −$2.53M
Current Liabilities Q2 2016 · Jun 30, 2016 $9.15M
Current Liabilities Q2 2016 · Dec 31, 2015 $3.24M
Total Liabilities Q2 2016 · Jun 30, 2016 $9.24M
Total Liabilities Q2 2016 · Dec 31, 2015 $3.33M
Current Assets Q2 2016 · Jun 30, 2016 $1.2M
Current Assets Q2 2016 · Dec 31, 2015 $300.74K
Total Assets Q2 2016 · Jun 30, 2016 $1.87M
Total Assets Q2 2016 · Dec 31, 2015 $805.09K
Sga Expense Q2 2016 · Jun 30, 2016 $792.76K
Sga Expense Q2 2016 · Jun 30, 2016 $1.73M
Sga Expense restated Q2 2016 · Jun 30, 2015 $1.45M
Sga Expense restated Q2 2016 · Jun 30, 2015 $3M
Rd Expense Q2 2016 · Jun 30, 2016 $665.72K
Rd Expense Q2 2016 · Jun 30, 2016 $1.35M
Rd Expense restated Q2 2016 · Jun 30, 2015 $698.8K
Rd Expense restated Q2 2016 · Jun 30, 2015 $1.47M
Net Income Q2 2016 · Jun 30, 2016 −$2.94M
Net Income Q2 2016 · Jun 30, 2016 −$5.56M
Net Income Q2 2016 · Jun 30, 2015 −$10.84M
Net Income Q2 2016 · Jun 30, 2015 −$19.15M
Operating Income Q2 2016 · Jun 30, 2016 −$1.48M
Operating Income Q2 2016 · Jun 30, 2016 −$3.14M
Operating Income restated Q2 2016 · Jun 30, 2015 −$12.27M
Operating Income restated Q2 2016 · Jun 30, 2015 −$14.78M
Revenue Q2 2016 · Jun 30, 2016 $0
Revenue Q2 2016 · Jun 30, 2016 $0
Revenue Q2 2016 · Jun 30, 2015 $0
Revenue Q2 2016 · Jun 30, 2015 $0